19-Dec-2025
SA Quant ranks cannabis stocks as Trump signs rescheduling order
Seeking Alpha News (Thu, 18-Dec 3:30 PM ET)
Cannabis stocks selling off as Trump signs rescheduling order
Seeking Alpha News (Thu, 18-Dec 2:21 PM ET)
Cannabis stocks selling off amid Trump’s rescheduling order
Seeking Alpha News (Thu, 18-Dec 1:55 PM ET)
OGI Sets New Benchmarks with Record Revenues, EBITDA, and Market Share Leadership in Fiscal 2025
Market Chameleon (Wed, 17-Dec 6:09 AM ET)
Pot stocks rally as Trump expected to sign executive order on rescheduling
Seeking Alpha News (Wed, 17-Dec 9:26 AM ET)
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and OrganiGram Holdings (OGI)
TipRanks (Wed, 17-Dec 3:50 AM ET)
Organigram Sets New Revenue Records and Expands Market Leadership in Fiscal 2025
Market Chameleon (Tue, 16-Dec 6:08 AM ET)
OGI Earnings Reaction: Why History Suggests Post-Earnings Bounces Are Rare
Market Chameleon (Tue, 16-Dec 4:56 AM ET)
Options Volatility and Implied Earnings Moves Today, December 16, 2025
TipRanks (Tue, 16-Dec 7:05 AM ET)
Organigram Achieves Record Financial Results and Expands Market Leadership
TipRanks (Tue, 16-Dec 6:38 AM ET)
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Organigram Global - Common Shares trades on the NASDAQ stock market under the symbol OGI.
As of December 19, 2025, OGI stock price declined to $2.01 with 2,078,946 million shares trading.
OGI has a beta of 1.24, meaning it tends to be more sensitive to market movements. OGI has a correlation of 0.15 to the broad based SPY ETF.
OGI has a market cap of $268.90 million. This is considered a Small Cap stock.
Last quarter Organigram Global - Common Shares reported $58 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.20.
In the last 3 years, OGI traded as high as $4.12 and as low as $.85.
The top ETF exchange traded funds that OGI belongs to (by Net Assets): MJ, YOLO, CNBS, DFIS, DFAX.
OGI has outperformed the market in the last year with a price return of +37.7% while the SPY ETF gained +18.1%. OGI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.7% and +21.8%, respectively, while the SPY returned +2.8% and -0.5%, respectively.
OGI support price is $1.94 and resistance is $2.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OGI shares will trade within this expected range on the day.